Multiple Sclerosis Diagnostic Test Navigation

|

Best products

Do you get dizzy or lightheaded? Then you
will want to check out Equitab

Are You Tired Of Sore Muscles?

The potent botanical ingredients in Myocil
work to help relax the muscle and to help repair
and rebuild damaged and strained tissue. You can
feel it start to work in as little as two days.
Myocil can work quickly to ease your pain,
discomfort, and swelling ..... Click Here For More

Are you sick of SPAM? Then Try this.
It is awesome! You can try for free and I know
you will love it!!
Click Here!

If you are looking for quality vitamin supplements then look no further.

USANA Essentials

 

Do you want to get your blog noticed?
Then try Blog Blaster.

Blog Blaster takes online Advertising to a new Level!
Submit your ad to 2 Million Blogs!

Best Multiple Sclerosis Diagnostic Test products

Cellscience Reviews Journal.
  Medical reviews Journal publishing articles from leading International authorities

No More MS. My Journey Back To Life
True Story of my recovery from Multiple Sclerosis.Near Death Experience.
Angel Encounters.
By Sue Ellen Dickenson

Newsletter

Main Multiple Sclerosis Diagnostic Test sponsors

Welcome to The Symptoms Of Multiple Sclerosis

	Enter your search terms
	Web www.thesymptomsofmultiplesclerosis.com Submit search form

Multiple Sclerosis Diagnostic Test Article

This is a selection among article about Multiple Sclerosis Diagnostic Test. For a permanent link to this article, or to bookmark it for further reading, click here.

With Reports Of Death, FDA Warns Multiple Sclerosis (MS) Patients Against Pharmaceutical Drug Tysabri

Greg Jones & Associates, a North Carolina-based law firm, in association with www.lawyersandsettlements.com, launches a marketing campaign to increase awareness of the Multiple Sclerosis drug, Tysabri. Makers of Tysabri, Biogen Idec Inc. and Elan Pharmaceuticals Inc., have recently taken the drug off the market and sent out warnings to doctors.

In November 2004, Biogen Idec and Elan Corporation received approval from the FDA to market and distribute Tysabri (natalizumab). Only four months later, February 2005, the drug was quickly removed from the market after the FDA received several reports of severe illness and death in patients prescribed Tysabri and Avonex. In several cases, the patient or corpse was diagnosed with Progressive Multifocal Leukoencephalopathy (PML), a rare brain infection that directly affects the central nervous system. Symptoms of PML are similar to a stroke: headaches, memory loss, speech and vision difficulties, limb weakness, and partial paralysis; the disease leads to coma then to death.

To date, approximately 3,000 patients have been involved in clinical trials or prescribed Tysabri for multiple sclerosis, Crohn's disease and rheumatoid arthritis. Biogen Idec and Elan Pharmaceuticals hope to redistribute the drug after extensive evaluations of Tysabri and the possible link to PML.

Biogen merged with IDEC Pharmaceuticals in 2003, creating the billion-dollar company, Biogen Idec, which is based in Cambridge, Massachusetts. Biogen Idec also has another MS drug in the news: the bread-winning drug, Avonex, the most widely prescribed Multiple Sclerosis drug in the world with revenues of $1.4 billion in 2004 has recently been linked to increased risk of liver damage and liver failure.

Greg Jones & Associates is urging patients that have had adverse side effects with the prescription drugs Tysabri or Avonex, to have their case reviewed at www.lawyersandsettlements.com; each case will be evaluated by a lawyer at no charge.

For more details about this product recall and potential class action lawsuit, visit https://www.lawyersandsettlements.com/case/tysabri

This article was posted on August 04, 2005

Multiple Sclerosis Diagnostic Test News

New study reveals potential role of TGF-1

Fibrosis in the kidney is one of the key causes of progressive renal failure. High levels of the inflammatory molecule TGF-1 in the kidney tubules due to tissue damage can cause fibrosis as well as nephron degeneration, resulting in loss of kidney function. To clarify the mechanisms regulating TGF-1-mediated renal fibrosis, Koesters et al expressed high levels of TGF-1 in renal tubules of ...

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2010

Abbott today announced financial results for the second quarter ended June 30, 2010.

Can a controversial new treatment for multiple sclerosis offer relief?

A new treatment is giving hope to MS sufferers such as Mark Walker. So why can't he get it in Britain? Liz Hunt reports

USF granted patent for cell transplantation procedure

The University of South Florida's Department of Neurosurgery and Brain Repair has been granted a patent for a cell transplantation procedure combining human umbilical cord blood cells and a sugar-alcohol compound called "mannitol" that may make a big difference in treating life-threatening neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and stroke ...

MS sufferers gain valuable insight into new treatment for disease

Staff writer A new treatment being explored by doctors has those dealing with the debilitating disease of Multiple Sclerosis (MS) hoping it's the relief they have been waiting for.[...]